Abstract:Objective To investigate the role of contrast enhanced ultrasound(CEUS) in evaluating and guiding radiofrequency ablation(RFA) of hepatocellular carcinoma(HCC) and its feeding vessels. Methods From January 2006 to June 2007, 71 patients with 75 hypervascular HCC in Peking University Cancer Hospital who underwent RFA were included in the study. The diagnosis was confirmed by ultrasound guided biopsy for all patients. These patients were not suitable for transcatheter arterial chemoembolization(TACE) or had poor responds to TACE. They were divided into two groups, which included group percutaneous artery ablation(PAA) combining RFA and group RFA. There were 38 patients with 39 HCC in group PAA combining RFA and CEUS were used to identify the range of HCC infiltration.Firstly, PAA of the feeding vessels was conducted under the guidance of color doplor flow imaging(CDFI).Then CEUS was performed to evaluate HCC perfusion after blocking the feeding vessels. Finally, the rest of the tumor was ablated by RFA. In group RFA, there were 33 patients with 36 HCC, who did not undertake PAA before RFA. Generally, the RFA was planned based on tumor size and location, and the ablation started with deep part of HCC or portion close to nearby organs. Contrast CT was used as a post-RFA imaging for follow-up at 1, 3 and 6 months post-RFA. T test was used to compare the difference in focal lesions number between two groups, and χ2tests were used to compare the difference in necrosis rate between two groups after treatment. Results In group PAA combining RFA, post-PAA CEUS showed intratumor perfusion decreased more than 70% in 31 HCC(79.5%, 31/39). Of them, 13 HCC(33.3%, 13/39) showed complete perfusion defect with clear margin, called "solar eclipse sign". The rest 8 HCC(20.5%, 8/39) showed 40%-70% of perfusion defect. In group PAA combining RFA, CDFI showed 35(83.3%, 35/42) feeding vessels were blocked, and 3 vessels(7.1%, 3/42) showed significant decreased flow signal after PAA. There were average 3.18±1.42 ablations per HCC in group PAA combining RFA, and 4.32±1.56 in group RFA. The number of ablations per HCC in group PAA combining RFA was significantly less than group RFA(t=2.524,P=0.015). The tumor necrosis rate at 1 month post-RFA in group PAA(92.3%, 36/39) combining RFA was significantly higher than that of group RFA(66.7%, 24/35)(χ2=8.264, P=0.001). Conclusions With CEUS,PAA can effectively block the feeding vessels of HCC, enhance ablated necrosis in the tumor and significantly increase necrosis rate post-RFA for large hypervascular HCC. CEUS-assisted PAA can improve efficiency of RFA with less ablation number and better result.

CT Arterioportography and CT Arteriography in Evaluating Therapeutic Response of Hepatic Malignancies after Radiofrequency Ablation

Assessment of Hepatocellular Carcinoma Undergoing Trans-Catheter Arterial Chemoembolization with Functional Magnetic Resonance Imaging

[Results of Enhanced Ultrasonography in Assessing Hepatoma Treated with Radiofrequency Ablation].

Primary Hepatocellular Carcimoma after Transcatheter Arterial Chemoembolization (TAC) with Radiofrequency Ablation (RFA): Spectrum of CT and MR Imaging Findings

Application of contrast-enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation

Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study

Evaluation of Short-Term Efficiency and Affecting Factors of Radiofrequency Ablation Guided by Sonography in Hepatic Malignant Tumors

Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation

The role of contrast enhanced ultrasound in evaluating and guiding radiofrequency ablation of hepatocellular carcinoma and feeding vessels

Ultrasound-guided radiofrequency ablation for the treatment of hepatic metastases:analysis of 136 cases

Radiofrequency Ablation Guided by Cone Beam Computed Tomography for Hepatocellular Carcinoma: a Comparative Study of Clinical Results with the Conventional Spiral Computed Tomography-Guided Procedure.

Clinical value of contrast enhanced ultrasound for identifying ablation range and designing treatment protocol of radiofrequency ablation in hepatocellular carcinoma

Clinical Short—term Results of Radiofrequency Ablation in L;iver Cancers

[Efficacy of Radiofrequency Ablation of 343 Patients with Hepatic Tumor and the Relevant Complications].

Combination of transcatheter arterial chemoembolization and radiofrequency ablation in hepatocellular carcinoma treatment

Comparative analysis of the efficacy and accuracy of magnetic resonance imaging (MRI) and contrast-enhanced CT for residual and new lesions after transcatheter arterial chemoembolization (TACE) in patients with primary liver cancer

Treatment Efficacy of Radiofrequency Ablation of 338 Patients with Hepatic Malignant Tumor and the Relevant Complications.

The role of contrast enhanced ultrasound in radiofrequency ablation of liver metastasis

Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings

[The Importance of Image Guided Radiofrequency Ablation with Standard Treatment Strategy for Liver Malignancies].

The clinical application of contrast enhanced ultrasonography in radiofrequency ablation therapy for residual and recurrent hepatic neoplasms